Get the latest delivered to your inbox
Privacy Policy

Now Reading

The Road to a Vaccine, Season 2, Ep. 2: How New COVID-19 Outbreaks Are Impacting a Global Return to Normal

The Road to a Vaccine, Season 2, Ep. 2: How New COVID-19 Outbreaks Are Impacting a Global Return to Normal

Published 07-21-20

Submitted by Johnson & Johnson

Click here to watch video

In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.

In Episode 2, Lisa Ling talks with Dr. Francis Collins, Director, NIH about the latest on treatments and vaccines. Also, Harvard's Dr. Ashish Jha shares how the virus affects the body and Johns Hopkins' Dr. Tom Inglesby explains what the new data on spread means for people.

Live at 12 PM EDT on Tuesdays

Tune in on JNJ.comFacebookLinkedIn or Twitter. Visit this page at any time to watch a replay.

Subscribe to JNJ on YouTube: http://www.youtube.com/subscription_c...
J&J on Facebook: http://www.facebook.com/jnj
JNJ News on Twitter: https://twitter.com/jnjnews
J&J on LinkedIn: https://www.linkedin.com/company/john...
J&J’s Latest News: https://www.jnj.com/latest-news

Johnson & Johnson Logo

Johnson & Johnson

Johnson & Johnson

Caring for the world, one person at a time... inspires and unites the people of Johnson & Johnson. This year, we celebrate 126 years of embracing research and science – bringing innovative ideas, products and services to advance the health and well-being of people. Employees of the Johnson & Johnson Family of Companies work in more than 250 operating companies in 60 countries throughout the world. The passion and commitment of our people yield innovations that further minimize our impact on the planet, drive new alliances to address major health challenges in developing and developed countries, and help to create economic opportunity for people. Improving human health and well-being is our crucial mission and the ultimate measure of upholding our responsibility now and for generations to come.

At Johnson & Johnson, our top priority is health-health of people and the planet. That's why we set aggressive corporate wide goals to reduce our environmental impact, outlined in our Healthy Future 2015 goals. To this end, we established the proprietary Earthwards® process for developing and marketing greener products through lifecycle analysis. Every Earthwards® recognized product must achieve a greater than 10 percent improvement in at least three of the seven goal areas:

  • Materials used
  • Packaging reduction
  • Energy reduction
  • Waste reduction
  • Water reduction
  • Positive social impact or benefit
  • Product innovation

More from Johnson & Johnson

Join today and get the latest delivered to your inbox